AI Article Synopsis
- The study aimed to evaluate how body mass index (BMI) affects the outcomes of in vitro fertilization (IVF) in infertile patients.
- A total of 573 patients were analyzed across four BMI categories during IVF cycles, revealing that obese patients required a higher dose of r-FSH for follicular development.
- Despite the increased medication dosage for obese patients, the study found that obesity did not negatively impact the overall success rates of IVF, such as implantation or pregnancy rates.
Article Abstract
Objective: To examine the outcome of in vitro fertilization according to the body mass index of infertile patients.
Study Design: Between September 2003 and May 2005, 573 patients underwent 789 in vitro fertilization cycles or ICSI because of male factor, tubal factor, and unexplained infertility were retrospectively included from our IVF database. The patients were classified in four groups: BMI<20 kg/m2 (264 cycles), 20< or = BMI<25 (394 cycles), 25< or = BMI < 30 (83 cycles), and BMI> or = 30 (48 cycles). All patients had a long protocol for IVF with a combination of the GnRH agonist and recombinant FSH.
Results: All parameters of ovarian response were comparable except the total required r-FSH dose. This dose was statistically higher in the group of BMI> or = 30 compared to the other groups (p = 0.0003). All parameters of IVF outcome were comparable, including the cancellation rate, the implantation rate, and pregnancy rates.
Conclusion: Obese patients require a higher r-FSH dose to achieve follicular maturation than normal weight patients. Obesity does not affect negatively results of in vitro fertilization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejogrb.2005.12.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!